Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases

Atherosclerosis (AS) is a systemic chronic disease affecting both the coronary and cerebral arteries. Inflammation plays a key role in the initiation and progression of AS, and numerous inflammatory factors have been proposed as potential biomarkers. This article reviews recent research in studies o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jun-Xuan Lv, Qi Kong, Xin Ma
Formato:	article
Lenguaje:	EN
Publicado:	KeAi Communications Co., Ltd. 2017
Materias:	Atherosclerosis Plaques Inflammatory biomarkers Risk factors Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/f0a36112a3344ffe82d688ae6d17c9a4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f0a36112a3344ffe82d688ae6d17c9a4
record_format	dspace
spelling	oai:doaj.org-article:f0a36112a3344ffe82d688ae6d17c9a42021-12-02T13:28:50ZCurrent advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases2095-882X10.1016/j.cdtm.2017.09.002https://doaj.org/article/f0a36112a3344ffe82d688ae6d17c9a42017-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095882X17300713https://doaj.org/toc/2095-882XAtherosclerosis (AS) is a systemic chronic disease affecting both the coronary and cerebral arteries. Inflammation plays a key role in the initiation and progression of AS, and numerous inflammatory factors have been proposed as potential biomarkers. This article reviews recent research in studies on major circulating inflammatory biomarkers to identify surrogates that may reflect processes associated with AS development and the risk of AS-related vascular events, such as Von Willebrand factor, lectin-like oxidized low-density-lipoprotein receptor-1, soluble urokinase plasminogen activator receptor, regulated upon activation, normal T-cell expressed and secreted, and microparticles, which may provide new perspectives for clinical AS evaluation and risk stratification.Jun-Xuan LvQi KongXin MaKeAi Communications Co., Ltd.articleAtherosclerosisPlaquesInflammatory biomarkersRisk factorsMedicine (General)R5-920ENChronic Diseases and Translational Medicine, Vol 3, Iss 4, Pp 207-212 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Atherosclerosis Plaques Inflammatory biomarkers Risk factors Medicine (General) R5-920
spellingShingle	Atherosclerosis Plaques Inflammatory biomarkers Risk factors Medicine (General) R5-920 Jun-Xuan Lv Qi Kong Xin Ma Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
description	Atherosclerosis (AS) is a systemic chronic disease affecting both the coronary and cerebral arteries. Inflammation plays a key role in the initiation and progression of AS, and numerous inflammatory factors have been proposed as potential biomarkers. This article reviews recent research in studies on major circulating inflammatory biomarkers to identify surrogates that may reflect processes associated with AS development and the risk of AS-related vascular events, such as Von Willebrand factor, lectin-like oxidized low-density-lipoprotein receptor-1, soluble urokinase plasminogen activator receptor, regulated upon activation, normal T-cell expressed and secreted, and microparticles, which may provide new perspectives for clinical AS evaluation and risk stratification.
format	article
author	Jun-Xuan Lv Qi Kong Xin Ma
author_facet	Jun-Xuan Lv Qi Kong Xin Ma
author_sort	Jun-Xuan Lv
title	Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
title_short	Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
title_full	Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
title_fullStr	Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
title_full_unstemmed	Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
title_sort	current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
publisher	KeAi Communications Co., Ltd.
publishDate	2017
url	https://doaj.org/article/f0a36112a3344ffe82d688ae6d17c9a4
work_keys_str_mv	AT junxuanlv currentadvancesincirculatinginflammatorybiomarkersinatherosclerosisandrelatedcardiocerebrovasculardiseases AT qikong currentadvancesincirculatinginflammatorybiomarkersinatherosclerosisandrelatedcardiocerebrovasculardiseases AT xinma currentadvancesincirculatinginflammatorybiomarkersinatherosclerosisandrelatedcardiocerebrovasculardiseases
_version_	1718393009004871680

Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases

Ejemplares similares